The impact of methotrexate and targeted immunosuppression on humoral and cellular immunogenicity of the COVID-19 vaccine BNT162b2 in people with psoriasis: a prospective longitudinal cohort study

Mahil, S.; Bechman, K.; Raharja, A.; Domingo-Vila, C.; Baudry, D.; Meynell, F.; Brown, M.; Cope, A.; Dasandi, T.; Graham, C.; Lechmere, T.; Malim, M.; Pollock, E.; Seow, J.; Sychowska, K.; Norton, S.; Barker, J.; Galloway, J.; Doores, K.; Tree, T.; Smith, C.

Mahil, S.; Bechman, K.; Raharja, A.; Domingo-Vila, C.; Baudry, D.; Meynell, F.; Brown, M.; Cope, A.; Dasandi, T.; Graham, C.; Lechmere, T.; Malim, M.; Pollock, E.; Seow, J.; Sychowska, K.; Norton, S.; Barker, J.; Galloway, J.; Doores, K.; Tree, T.; Smith, C..

British Journal of Dermatology ; 186(1):E11-E11, 2022.

Article in English | Web of Science | ID: covidwho-1615253

Keywords

Dermatology

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Language: English Journal: British Journal of Dermatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML